Variant report
Variant | esv3315146 |
---|---|
Chromosome Location | chr17:15183136-15186071 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:21)
- CpG islands (count:61)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:21 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr17:15185220-15185382 | HepG2 | liver: | n/a | n/a |
2 | CEBPB | chr17:15185212-15185442 | A549 | lung: | n/a | n/a |
3 | CEBPB | chr17:15185177-15185512 | HepG2 | liver: | n/a | n/a |
4 | CEBPB | chr17:15185126-15185445 | ECC-1 | luminal epithelium: | n/a | n/a |
5 | CEBPB | chr17:15185220-15185528 | H1-hESC | embryonic stem cell: | n/a | n/a |
6 | CEBPB | chr17:15185153-15185422 | HepG2 | liver: | n/a | n/a |
7 | CEBPB | chr17:15185162-15185560 | A549 | lung: | n/a | n/a |
8 | CEBPB | chr17:15185168-15185511 | Hela-S3 | cervix: | n/a | n/a |
9 | CEBPB | chr17:15185182-15185520 | ECC-1 | luminal epithelium: | n/a | n/a |
10 | CEBPB | chr17:15185150-15185532 | IMR90 | lung: | n/a | n/a |
11 | CEBPB | chr17:15185127-15185551 | MCF-7 | breast: | n/a | n/a |
12 | CEBPB | chr17:15185144-15185529 | HepG2 | liver: | n/a | n/a |
13 | CEBPB | chr17:15185173-15185515 | K562 | blood: | n/a | n/a |
14 | CEBPB | chr17:15185094-15185596 | MCF-7 | breast: | n/a | n/a |
15 | E2F4 | chr17:15185360-15185377 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | FOS | chr17:15183549-15183577 | MCF10A-Er-Src | breast: | n/a | n/a |
17 | GATA3 | chr17:15182015-15183186 | A549 | lung: | n/a | n/a |
18 | HNF4A | chr17:15185237-15185393 | HepG2 | liver: | n/a | n/a |
19 | MAX | chr17:15181610-15183338 | A549 | lung: | n/a | chr17:15182713-15182723 |
20 | MAX | chr17:15182162-15183271 | A549 | lung: | n/a | chr17:15182713-15182723 |
21 | SETDB1 | chr17:15185773-15186342 | U2OS | brain: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr17:15183229-15183279 | HRPEpiC | eye: | n/a |
2 | chr17:15183229-15183279 | MCF10A-Er-Src | breast: | n/a |
3 | chr17:15183229-15183279 | RPTEC | kidney: | n/a |
4 | chr17:15183229-15183279 | T-47D | breast: | n/a |
5 | chr17:15183229-15183279 | PANC-1 | pancreas: | n/a |
6 | chr17:15183229-15183279 | GM12878 | blood: | n/a |
7 | chr17:15183229-15183279 | AG10803 | skin: | n/a |
8 | chr17:15183229-15183279 | NT2-D1 | testis: | n/a |
9 | chr17:15183229-15183279 | Hepatocyte | liver: | n/a |
10 | chr17:15183229-15183279 | HIPEpiC | eye: | n/a |
11 | chr17:15183229-15183279 | HepG2 | liver: | n/a |
12 | chr17:15183229-15183279 | HEK293 | kidney: | embryo |
13 | chr17:15183229-15183279 | NHDF-neo | bronchial: | n/a |
14 | chr17:15183229-15183279 | ECC-1 | luminal epithelium: | n/a |
15 | chr17:15183229-15183279 | SAEC | small airway: | n/a |
16 | chr17:15183229-15183279 | HCT-116 | colon: | n/a |
17 | chr17:15183229-15183279 | NHBE | bronchial: | n/a |
18 | chr17:15183229-15183279 | GM06990 | blood: | n/a |
19 | chr17:15183229-15183279 | HMEC | breast: | n/a |
20 | chr17:15183229-15183279 | K562 | blood: | n/a |
21 | chr17:15183229-15183279 | NH-A | brain: | n/a |
22 | chr17:15183229-15183279 | Caco-2 | colon: | n/a |
23 | chr17:15183229-15183279 | ProgFib | skin: | n/a |
24 | chr17:15183229-15183279 | LNCaP | prostate: | n/a |
25 | chr17:15183229-15183279 | ovcar-3 | ovarian: | n/a |
26 | chr17:15183229-15183279 | IMR90 | lung: | fetal |
27 | chr17:15183229-15183279 | MCF-7 | breast: | n/a |
28 | chr17:15183229-15183279 | A549 | lung: | n/a |
29 | chr17:15183229-15183279 | AG09309 | skin: | n/a |
30 | chr17:15183229-15183279 | PrEC | prostate: | n/a |
31 | chr17:15183229-15183279 | HRCEpiC | kidney: | n/a |
32 | chr17:15183229-15183279 | AoSMC | blood vessel: | n/a |
33 | chr17:15183229-15183279 | GM12892 | blood: | n/a |
34 | chr17:15183229-15183279 | HNPCEpiC | eye: | n/a |
35 | chr17:15183229-15183279 | HCPEpiC | choroid plexus: | n/a |
36 | chr17:15183229-15183279 | SK-N-SH_RA | brain: | n/a |
37 | chr17:15183229-15183279 | AG09319 | gingival: | n/a |
38 | chr17:15183229-15183279 | Jurkat | blood: | n/a |
39 | chr17:15183229-15183279 | GM12891 | blood: | n/a |
40 | chr17:15183229-15183279 | H1-hESC | embryonic stem cell: | embryo |
41 | chr17:15183229-15183279 | HAEpiC | amniotic membrane: | n/a |
42 | chr17:15183229-15183279 | HUVEC | blood vessel: | n/a |
43 | chr17:15183229-15183279 | SKMC | muscle: | n/a |
44 | chr17:15183229-15183279 | GM19239 | blood: | n/a |
45 | chr17:15183229-15183279 | NB4 | blood: | n/a |
46 | chr17:15183229-15183279 | HRE | kidney: | n/a |
47 | chr17:15183229-15183279 | HEEpiC | esophagus: | n/a |
48 | chr17:15183229-15183279 | HL-60 | blood: | n/a |
49 | chr17:15183229-15183279 | BJ | skin: | n/a |
50 | chr17:15183229-15183279 | SK-N-SH | brain: | n/a |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000237377 | TF binding region |
ENSG00000237377 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs9894454 | chr17:15183182-15183183 | Enhancers Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs377699695 | chr17:15183183-15183184 | Enhancers Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs188442664 | chr17:15183192-15183193 | Enhancers Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs558702117 | chr17:15183203-15183204 | Enhancers Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs564701743 | chr17:15183229-15183230 | Enhancers Weak transcription Flanking Active TSS | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs76476804 | chr17:15183230-15183231 | Enhancers Weak transcription Flanking Active TSS | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs76920564 | chr17:15183271-15183272 | Enhancers Weak transcription Flanking Active TSS | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs34432599 | chr17:15183272-15183273 | Enhancers Weak transcription Flanking Active TSS | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs375888594 | chr17:15183275-15183276 | Enhancers Weak transcription Flanking Active TSS | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs397762611 | chr17:15183276-15183277 | Enhancers Weak transcription Flanking Active TSS | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs80343157 | chr17:15183277-15183278 | Enhancers Weak transcription Flanking Active TSS | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs199996635 | chr17:15183279-15183280 | Enhancers Weak transcription Flanking Active TSS | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs35386588 | chr17:15183296-15183297 | Enhancers Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs397796905 | chr17:15183302-15183303 | Enhancers Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs148295259 | chr17:15183309-15183310 | Enhancers Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs77660907 | chr17:15183317-15183318 | Enhancers Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs530315544 | chr17:15183394-15183395 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs538718172 | chr17:15183438-15183439 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs140632748 | chr17:15183515-15183516 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs538934744 | chr17:15183586-15183587 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs16951285 | chr17:15183627-15183628 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
22 | rs112953058 | chr17:15183737-15183738 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs113114059 | chr17:15183764-15183765 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs147107525 | chr17:15183819-15183820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs12449862 | chr17:15183829-15183830 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
26 | rs181257449 | chr17:15183839-15183840 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs574631593 | chr17:15183843-15183844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs543907873 | chr17:15183925-15183926 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs138488670 | chr17:15184111-15184112 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs576210526 | chr17:15184120-15184121 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs34320730 | chr17:15184130-15184131 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs544943971 | chr17:15184239-15184240 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs555042576 | chr17:15184300-15184301 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs565212131 | chr17:15184335-15184336 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs141640805 | chr17:15184337-15184338 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs199774063 | chr17:15184368-15184369 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs541075797 | chr17:15184388-15184389 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs560956978 | chr17:15184439-15184440 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs529707639 | chr17:15184510-15184511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs147380016 | chr17:15184528-15184529 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs541843992 | chr17:15184547-15184548 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs113245138 | chr17:15184623-15184624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs530608061 | chr17:15184631-15184632 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs75976060 | chr17:15184679-15184680 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs183493968 | chr17:15184700-15184701 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs111241560 | chr17:15184716-15184717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs534687639 | chr17:15184749-15184750 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs149480705 | chr17:15184780-15184781 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs189188094 | chr17:15184783-15184784 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs143893001 | chr17:15184823-15184824 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 17603634 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Chordoma | 21602918 | CNVD |
Miller-Dieker syndrome | 22283845 | CNVD |
Non-syndromic sensorineural hearing loss | 17457615 | CNVD |
Cancer | 22429812 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Breast cancer | 22028636 | CNVD |
Breast cancer | 20837533 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
colon cancer | 17210682 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Chronic lymphocytic leukemia | 17971485 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 16461572 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Breast cancer | 17133270 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Moyamoya disease | 22323933 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Colorectal cancer | 21645411 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
HIV/AIDS | 17953491 | CNVD |
HIV/AIDS | 20877625 | CNVD |
Immune disease | 21076436 | CNVD |
Rheumatoid arthritis | 17953491 | CNVD |
Type 1 diabetes | 17953491 | CNVD |
HIV/AIDS | 15637236 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Neurofibromatosis | 18196300 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21509527 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Autism | 17322880 | CNVD |
Hereditary neuropathy with liability to pressure palsy | 19521722 | CNVD |
Schizophrenia | 19571808 | CNVD |
Schizophrenia | 19955444 | CNVD |
Charcot-marie-tooth disease | 18787571 | CNVD |
Breast cancer | 20409316 | CNVD |
Autism | 18414403 | CNVD |
Breast cancer | 17001317 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Peripheral neuropathy | 21193943 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 22958593 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Charcot-marie-tooth disease | 16463004 | CNVD |
Osteosarcoma | 22292074 | CNVD |
Charcot | 16760730 | CNVD |
Mental retardation | 17901693 | CNVD |
ovarian endometriomas | 16273235 | CNVD |
Breast cancer | 21858162 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Schizophrenia | 20967226 | CNVD |
Autism | 18522746 | CNVD |
Epilepsy | 21635232 | CNVD |
Autism | 22543975 | CNVD |
Obesity | 20622171 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17142309 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:15173200-15192600 | Weak transcription | Left Ventricle | heart |
2 | chr17:15180800-15183600 | Enhancers | Hela-S3 | cervix |
3 | chr17:15181600-15183400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
4 | chr17:15181600-15183400 | Flanking Active TSS | A549 | lung |
5 | chr17:15181800-15183200 | Enhancers | HSMMtube | muscle |
6 | chr17:15182200-15183200 | Enhancers | HMEC | breast |
7 | chr17:15182200-15183200 | Enhancers | NH-A | brain |
8 | chr17:15182200-15183200 | Enhancers | NHLF | lung |
9 | chr17:15182200-15183600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
10 | chr17:15182200-15187600 | Weak transcription | Fetal Heart | heart |
11 | chr17:15182400-15183200 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
12 | chr17:15182400-15183400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
13 | chr17:15182400-15183400 | Enhancers | Muscle Satellite Cultured Cells | -- |
14 | chr17:15182400-15183600 | Enhancers | NHDF-Ad | bronchial |
15 | chr17:15182400-15184800 | Weak transcription | HSMM | muscle |
16 | chr17:15182800-15183200 | Enhancers | Osteobl | bone |
17 | chr17:15183000-15183200 | Enhancers | Right Atrium | heart |
18 | chr17:15183000-15183400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
19 | chr17:15183200-15183800 | Weak transcription | Right Atrium | heart |
20 | chr17:15183200-15185200 | Weak transcription | NH-A | brain |
21 | chr17:15183200-15189000 | Weak transcription | HSMMtube | muscle |
22 | chr17:15183600-15185000 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
23 | chr17:15185000-15185400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
24 | chr17:15185200-15185600 | Enhancers | NH-A | brain |
25 | chr17:15185400-15191200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |